TVM leads €25m series-A for Centogene

The funding round saw private equity house Deutsche Private Equity, Luxembourg-based fund manager Careventures and CIC Capital, the private equity arm of asset management firm CM-CIC Investissement, take part in the transaction.

The company intends to use the fresh capital to accelerate its expansion in the genetic testing and big data sectors. Additionally, it aims to further expand across the US and China, and strengthen its presence in the MENA region and Latin America.

Following the transaction, TVM managing partner Hubery Birner, Careventures managing partner Eric Souetre and Deutsche Private Equity partner Guido Prehn will join the company's supervisory board.

Company
Headquartered in Rostock, Centogene provides genetic diagnostics for rare diseases. Founded in 2005, the company also manages a data portfolio for hereditary disorders, receiving samples from 110 countries. According to its website, the business has 300 employees and claims a 40% compound annual growth rate over the last five years.

People
TVM Capital Life Science – Hubert Birner (managing partner).
Deutsche Private Equity – Guido Prehn (partner).
Careventures – Eric Souetre (managing partner).
CIC Capital – Sebastien Neiss (director).
Centogene – Arndt Rolfs (founder, CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Healthcare
• DACH
• Venture
• Germany